PRIMARY STUDY
Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer
Key Findings: The data from the trial demonstrated the potential therapeutic effects of a flavonoid derived from cannabis (the unnatural isomer of Cannflavin B) in the treatment of metastatic pancreatic cancer. In vitro results showed major increase in apoptosis while in vivo results demonstrate therapeutic efficacy in delaying both local and metastatic tumor progression in the animal models.
Type of Study: Animal Study
Study Result: Positive
Research Location(s): United States
Year of Pub: 2019
Cannabinoids Studied: Cannabinoid (unspecified)
Phytocannabinoid Source: Not Applicable
Citation: Moreau M, et al. Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer. Front Oncol. 2019; 9:660. doi: 10.3389/fonc.2019.00660
Authors: Moreau M, Ibeh U, Decosmo K, Bih N, Yasmin-Karim S, Toyang N, Lowe H, Ngwa W
